TY - JOUR
T1 - Does plastic surgical consultation improve the outcome of patients undergoing radical vulvectomy for squamous cell carcinoma of the vulva?
AU - Aviki, Emeline M.
AU - Esselen, Katharine M.
AU - Barcia, Sara M.
AU - Nucci, Marisa R.
AU - Horowitz, Neil S.
AU - Feltmate, Colleen M.
AU - Berkowitz, Ross S.
AU - Orgill, Dennis G.
AU - Viswanathan, Akila N.
AU - Muto, Michael G.
PY - 2015/1/1
Y1 - 2015/1/1
N2 - Objectives. To analyze margin status and prognostic factors for complications in patients undergoing vulvectomy for invasive squamous cell cancer (iSCC) with and without plastic-assisted closure. Methods. Demographic and clinical data were collected on 94 patientswith iSCCwho underwent vulvectomy between 2004 and 2013. All pathology slides were re-reviewed by two gynecologic pathologists. Data were analyzed using XLSTAT-Pro v2014.2.02. Results. Of 88 eligible patients, 15 (17%) had plastic-assisted vulvar closure and 73 (83%) did not. There were significantly more patients in the plastics groupwith recurrent disease (53% v 10%) and history radiation therapy prior to surgery (40% versus 5%). Plastic-assisted closure was associated with larger tumors (3.73 cm versus 2.03 cm, p < 0.01) and a higher frequency of adequate margins (53% versus 29%, p = 0.06). For tumors ≥3.0 cm, plastic-assisted closure was significantly associated with adequate margins (44% versus 6%, p = 0.03). Prior radiation usewas associatedwith plastic-assisted closure, larger tumors, older age, and recurrent disease. Complications occurred in 36 patients (41%) and significantly more occurred in those with plastic-assisted closure (67% versus 36%, p=0.04). Onmultivariate analysis including age, tumor size, recurrent disease, plasticassisted closure, and history of radiation, only history of radiation therapy was a significant predictor of complications (OR = 17, 95%CI 2.05-141.35; p = 0.01). Conclusions. Plastic-assisted vulvectomy closure was more often utilized in cases involving past radiation therapy and larger tumors. Plastic-assisted closure significantly increased the frequency of adequate margins in tumors ≥3 cm and did not impact complications.
AB - Objectives. To analyze margin status and prognostic factors for complications in patients undergoing vulvectomy for invasive squamous cell cancer (iSCC) with and without plastic-assisted closure. Methods. Demographic and clinical data were collected on 94 patientswith iSCCwho underwent vulvectomy between 2004 and 2013. All pathology slides were re-reviewed by two gynecologic pathologists. Data were analyzed using XLSTAT-Pro v2014.2.02. Results. Of 88 eligible patients, 15 (17%) had plastic-assisted vulvar closure and 73 (83%) did not. There were significantly more patients in the plastics groupwith recurrent disease (53% v 10%) and history radiation therapy prior to surgery (40% versus 5%). Plastic-assisted closure was associated with larger tumors (3.73 cm versus 2.03 cm, p < 0.01) and a higher frequency of adequate margins (53% versus 29%, p = 0.06). For tumors ≥3.0 cm, plastic-assisted closure was significantly associated with adequate margins (44% versus 6%, p = 0.03). Prior radiation usewas associatedwith plastic-assisted closure, larger tumors, older age, and recurrent disease. Complications occurred in 36 patients (41%) and significantly more occurred in those with plastic-assisted closure (67% versus 36%, p=0.04). Onmultivariate analysis including age, tumor size, recurrent disease, plasticassisted closure, and history of radiation, only history of radiation therapy was a significant predictor of complications (OR = 17, 95%CI 2.05-141.35; p = 0.01). Conclusions. Plastic-assisted vulvectomy closure was more often utilized in cases involving past radiation therapy and larger tumors. Plastic-assisted closure significantly increased the frequency of adequate margins in tumors ≥3 cm and did not impact complications.
KW - Complications
KW - Plastics surgery
KW - Squamous cell cancer
KW - Tumor margins
KW - Vulvar cancer
KW - Vulvectomy
UR - http://www.scopus.com/inward/record.url?scp=84929939794&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84929939794&partnerID=8YFLogxK
U2 - 10.1016/j.ygyno.2015.02.001
DO - 10.1016/j.ygyno.2015.02.001
M3 - Article
C2 - 25667974
AN - SCOPUS:84929939794
SN - 0090-8258
VL - 137
SP - 60
EP - 65
JO - Gynecologic Oncology
JF - Gynecologic Oncology
IS - 1
ER -